Project Details
Description
Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/19 → 1/30/20 |
Funding
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.